TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/24/25 17:35 | 3/20/25 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | M.d | 0 | 0.00 | 0 | 6 | 59 | 17 | D | ||||||||||||||
3/24/25 17:35 | 3/21/25 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S.d | -91 | 41.23 | 0 | -2 | -12 | 17 | D | ||||||||||||||
3/18/25 17:35 | 3/14/25 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | M.d | 0 | 0.00 | 0 | 10 | 368 | 13 | D | ||||||||||||||
3/18/25 17:35 | 3/17/25 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S.d | -157 | 41.80 | 0 | -4 | -23 | 13 | D | ||||||||||||||
3/18/24 17:45 | 3/14/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | M.d | 0 | 0.00 | 0 | 10 | 6 | D | |||||||||||||||
3/18/24 17:45 | 3/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Prasad Raju | MA | O | CFO | S.d | -256 | 72.69 | 0 | -4 | -35 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |